Table 2.
COVID-19-related clinical, radiological, and biological characteristics on first examination (at the emergency department unit or IHU).
| Variable | Data Available | All (n = 344) |
Oupatients (n = 159) |
Inpatients (n = 185) |
p |
|---|---|---|---|---|---|
| Positive SARS-CoV-2-PCR | 344 | 330 (96%) | 158 (99.4%) | 172 (93%) | 0.002 |
| Typical CT signs | 288 | 246 (85.4%) | 96 (78%) | 150 (88%) | |
| limited | 87 (35.3%) | 59 (61.5%) | 28 (19%) | <0.05 | |
| limited to intermediate | 4 (1.6%) | 0 (0%) | 4 (2.6%) | NS | |
| intermediate | 96 (39%) | 35 (36.5%) | 61 (41%) | NS | |
| intermediate to severe | 8 (3.2%) | 0 (0%) | 8 (5.3%) | NS | |
| severe | 51 (2.2%) | 2 (2%) | 49 (32.1%) | <0.05 | |
| COVID-19 symptoms | 343 | 324 (94.5%) | 144 (90.6%) | 180 (97.8%) | 0.004 |
| Fever | 340 | 165 (48.5%) | 47 (29.6%) | 118 (65.2%) | <0.0001 |
| Cough | 340 | 217 (63.8%) | 92 (57.9%) | 125 (69.1%) | 0.040 |
| Dyspnea | 343 | 133 (38.8%) | 27 (17%) | 106(57.6%) | <0.0001 |
| Cephalalgia | 339 | 77 (22.7%) | 51 (32.1%) | 26 (14.4%) | <0.0001 |
| Anosmia and/or agueusia | 340 | 115 (33.4%) | 85 (53.5%) | 30 (16.6%) | <0.0001 |
| Fatigue | 340 | 205 (60.3%) | 80 (50.3%) | 125 (69.1%) | 0.001 |
| Rhinitis and/or pharyngeal symptoms | 340 | 69 (20.3%) | 55 (34.6%) | 14 (7.7%) | <0.0001 |
| Digestive disorder | 340 | 77 (22.6%) | 31 (19.5%) | 46 (25.4%) | NS |
| Time between symptoms and first day hospital or consultations | 332 | 6 ± 4.6 | 5.8 ± 4.5 | 6.2 ± 4.6 | 0.002 |
| Secondary infection | 336 | 19 (5.7%) | 0 (0%) | 19 (10.7%) | <0.0001 |
| Ketosis | 340 | 7 (2.1%) | 2 (1.3%) | 5 (2.8%) | NS |
| Peripheral oxygen saturation (%) | 313 | 94.3 ± 6.7 | 97.3 ± 1.5 | 91.6 ± 8.3 | <0.0001 |
| Biology at admission | |||||
| Hemoglobin (g/dL) | 330 | 13.4 ± 1.8 | 13.8 ± 1.5 | 13.1 ± 2.0 | <0.0001 |
| White cell count (G/L) | 330 | 6.6 ± 2.7 | 6.0 ± 1.7 | 7.0 ± 3.2 | <0.0001 |
| Lymphocyte count (G/L) | 311 | 1.5 ± 0.9 | 1.8 ± 0.8 | 1.2 ± 0.9 | <0.0001 |
| Neutrophil count (G/L) | 311 | 4.4 ± 2.4 | 3.6 ± 1.5 | 5.1 ± 2.8 | <0.0001 |
| Eosinophil count (G/L) | 311 | 0.02 (0–0.07) | 0.07 ± 0.1 | 0.04 ± 0.144 | NS |
| Platelet count (103/mm3) | 330 | 225 ± 85 | 244 ± 83 | 211 ± 84 | <0.0001 |
| eGFR (/min) | 331 | 77 ± 28.8 | 91.8 ± 21.7 | 66.2 ± 28.7 | <0.0001 |
| Admission plasma glucose (mmol/L) | 324 | 10 ± 5.2 | 9.2 ± 4.2 | 10.7 ± 5.8 | 0.010 |
| ASAT (UI/L) | 292 | 44 ± 30 | 34 ± 18 | 50 ± 35 | <0.0001 |
| ALAT (UI/L) | 292 | 38 ± 28 | 39 ± 26 | 37 ± 30 | NS |
| GGT (UI/L) | 292 | 44 (26–69) | 57 ± 58 | 73 ± 123 | NS |
| CRP (mg/L) | 299 | 32 (5.8–87) | 18.9 ± 33.6 | 88. ± 81.8 | <0.0001 |
| CPK (UI/L) | 280 | 100 (59–191) | 77 (56–134) | 121 (67–257) | 0.001 |
| LDH (UI/L) | 269 | 304 ± 138 | 232.6 ± 56 | 351.2 ± 155 | <0.0001 |
| Albumin (g/L) | 211 | 38 ± 6 | 43 ± 4 | 37 ± 5 | <0.0001 |
Data are represented as numbers (%) and mean ± SD or median (25th–75th percentile). eGFR, estimated glomerular filtration rate eGFR was calculated according to the CKD-EPI formula. GGT, gamma glutamyl transferase. LDH, lactate dehydrogenase.